BRIEF published on 01/27/2026 at 18:05, 6 days 1 hour ago Theranexus Liquidity Contract Half-Year Review Liquidity Contract PORTZAMPARC Financial Report Theranexus THX Pharma Actions
BRIEF published on 01/27/2026 at 18:05, 6 days 1 hour ago Bilan semestriel du contrat de liquidité de Theranexus Contrat De Liquidité PORTZAMPARC Bilan Financier Theranexus Actions THX Pharma
PRESS RELEASE published on 01/27/2026 at 18:00, 6 days 1 hour ago BILAN SEMESTRIEL DU CONTRAT DE LIQUIDITÉ CONFIÉ À PORTZAMPARC THX Pharma publie le bilan semestriel de son contrat de liquidité confié à Portzamparc. Détails des titres et montants du compte de liquidité au 31/12/2025 Contrat De Liquidité Bilan Semestriel PORTZAMPARC Maladies Neurologiques Rares THX Pharma
BRIEF published on 01/20/2026 at 18:05, 13 days 1 hour ago THX Pharma dévoile son calendrier financier pour 2026 Calendrier Financier Maladies Neurologiques THX Pharma Annonces De 2026 Communication Marketing
BRIEF published on 01/20/2026 at 18:05, 13 days 1 hour ago THX Pharma Reveals 2026 Financial Schedule Financial Calendar Neurological Diseases Market Communication 2026 Announcements THX Pharma
BRIEF published on 01/20/2026 at 18:05, 13 days 1 hour ago THX Pharma dévoile son calendrier financier 2026 Euronext Paris Agenda Financier Biopharmaceutique 2026 THX Pharma
BRIEF published on 01/20/2026 at 18:05, 13 days 1 hour ago THX Pharma unveils its 2026 financial calendar Euronext Paris Financial Agenda Biopharmaceutical 2026 THX Pharma
PRESS RELEASE published on 01/20/2026 at 18:00, 13 days 1 hour ago THX Pharma Announces its 2026 Financial Calendar THX Pharma (Theranexus) announces financial communication agenda for 2026, focusing on rare neurological diseases treatments. Company listed on Euronext Growth Paris Euronext Growth Paris Financial Communication Theranexus Neurological Diseases THX Pharma
PRESS RELEASE published on 01/20/2026 at 18:00, 13 days 1 hour ago THX Pharma publie son agenda financier 2026 THX Pharma publie son agenda financier 2026, incluant les dates de communication financière et informations sur ses médicaments innovants. Retrouvez plus d'informations sur http://www.theranexus.com Communication Financière Agenda Financier Médicaments Neurologiques Rares THX Pharma
BRIEF published on 01/08/2026 at 18:05, 25 days 1 hour ago THX Pharma publie une lettre aux actionnaires Biopharmaceutique Communication Aux Actionnaires Développement De Médicaments Maladies Neurologiques THX Pharma
Published on 02/02/2026 at 15:00, 4 hours 38 minutes ago Jericho Energy Ventures Strategically Terminates SmartKem LOI to Advance Independent Data Center Energy Infrastructure Platform
Published on 02/02/2026 at 14:30, 5 hours 8 minutes ago Unusual Machines Promotes Drew Camden to President
Published on 02/02/2026 at 14:30, 5 hours 8 minutes ago Predictiv AI Provides Pilot Update from Innovate Calgary's Soaring Higher Challenge with Calgary Airports and WestJet
Published on 02/02/2026 at 14:30, 5 hours 8 minutes ago NanoViricides President Dr. Diwan Interviewed by Mission Matters' Adam Torres
Published on 02/02/2026 at 14:00, 5 hours 38 minutes ago Paymetrex Launches Patent Licensing Program to Monetize Mobile Payments IP Portfolio
Published on 02/02/2026 at 19:05, 32 minutes ago Virtual Science AI launches the life science industry's first medical congress AI solution for real-time event conversational intelligence
Published on 02/02/2026 at 19:00, 38 minutes ago PATRIMOINE ET COMMERCE: INFORMATIONS RELATIVES AU NOMBRE TOTAL DE DROITS DE VOTE ET AU NOMBRE D’ACTIONS COMPOSANT LE CAPITAL SOCIAL AU TITRE DE L’ARTICLE 223-16 DU REGLEMENT GENERAL DE L'AMF
Published on 02/02/2026 at 19:00, 38 minutes ago PATRIMOINE ET COMMERCE: Déclaration des transactions sur actions propres (Hors contrat de liquidité) réalisées du 26 JANVIER 2026 au 30 JANVIER 2026
Published on 02/02/2026 at 18:59, 38 minutes ago EQS-Adhoc: Deutsche Rohstoff AG: Oil and Gas Reserves increase by 46% – NPV of USD 542 million at USD 60 WTI oil price
Published on 02/02/2026 at 18:59, 39 minutes ago EQS-Adhoc: BayWa AG: BayWa AG Executive Board in precautionary talks with financing partners and major shareholders regarding potential adjustments of restructuring concept
Published on 02/02/2026 at 18:23, 1 hour 14 minutes ago Monthly disclosure of the total number of shares and voting rights - January 2026
Published on 02/02/2026 at 18:23, 1 hour 14 minutes ago TF1 - Déclaration mensuelle des actions et droits de vote - Janvier 2026
Published on 02/02/2026 at 18:00, 1 hour 38 minutes ago Covivio - Information on total number of voting rights and share capital
Published on 02/02/2026 at 18:00, 1 hour 38 minutes ago Covivio Hotels - Informations relatives au nombre total de droits de vote et d’actions composant le capital social
Published on 02/02/2026 at 18:00, 1 hour 38 minutes ago Covivio - Informations relatives au nombre total de droits de vote et d’actions composant le capital social
